Anti-fibrinolytic Sustained Release Tablet contains Tranexamic Acid in the strength of 750 mg. The Sustained Release Tablet, available under the brand name "Pause SR" is used as Antifibrinolytics in pharmaceutical applications. Anti-fibrinolytic Sustained Release Tablet is manufactured by Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Also manufactures a wide range of pharmaceutical products based on API, formulations and biotechnology such as tablets, oral formulations, injections, soft gel, capsules, drops and suspensions. The Anti-fibrinolytic Sustained Release Tablet comes in strips form containing 10 tablets in each.